Literature DB >> 8340986

Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus.

.   

Abstract

Convulsive status epilepticus is an emergency that is associated with high morbidity and mortality. The outcome largely depends on etiology, but prompt and appropriate pharmacological therapy can reduce morbidity and mortality. Etiology varies in children and adults and reflects the distribution of disease in these age groups. Antiepileptic drug administration should be initiated whenever a seizure has lasted 10 minutes. Immediate concerns include supporting respiration, maintaining blood pressure, gaining intravenous access, and identifying and treating the underlying cause. Initial therapeutic and diagnostic measures are conducted simultaneously. The goal of therapy is rapid termination of clinical and electrical seizure activity; the longer a seizure continues, the greater the likelihood of an adverse outcome. Several drug protocols now in use will terminate status epilepticus. Common to all patients is the need for a clear plan, prompt administration of appropriate drugs in adequate doses, and attention to the possibility of apnea, hypoventilation, or other metabolic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8340986

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  79 in total

Review 1.  Emergency department drug therapy for status epilepticus in adults.

Authors:  A S Lockey
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740

Review 2.  Treatment of status epilepticus in children.

Authors:  M De Negri; M G Baglietto
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Hippocampal Malrotation Is Associated With Prolonged Febrile Seizures: Results of the FEBSTAT Study.

Authors:  Stephen Chan; Jacqueline A Bello; Shlomo Shinnar; Dale C Hesdorffer; Darrell V Lewis; James MacFall; Ruth C Shinnar; William Gomes; Claire Litherland; Yuan Xu; Douglas R Nordli; John M Pellock; L Matthew Frank; Solomon L Moshé; Shumei Sun
Journal:  AJR Am J Roentgenol       Date:  2015-11       Impact factor: 3.959

4.  Recent and future advances in the treatment of status epilepticus.

Authors:  Felix Rosenow; Susanne Knake
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

5.  Status epilepticus.

Authors:  Panayiotis N Varelas; Marek A Mirski
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

Review 6.  Treatment of Generalized Convulsive Status Epilepticus in Pediatric Patients.

Authors:  Elizabeth L Alford; James W Wheless; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Jul-Aug

7.  Seizure-induced changes in place cell physiology: relationship to spatial memory.

Authors:  Xianzeng Liu; Robert U Muller; Li-Tung Huang; John L Kubie; Alexander Rotenberg; Bruno Rivard; Maria Roberta Cilio; Gregory L Holmes
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

8.  Status epilepticus in Indian children in a tertiary care center.

Authors:  Sheffali Gulati; Veena Kalra; M R Sridhar
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

9.  MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study.

Authors:  Shlomo Shinnar; Jacqueline A Bello; Stephen Chan; Dale C Hesdorffer; Darrell V Lewis; James Macfall; John M Pellock; Douglas R Nordli; L Matthew Frank; Solomon L Moshe; William Gomes; Ruth C Shinnar; Shumei Sun
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

10.  Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts.

Authors:  Luca Vignatelli; Rita Rinaldi; Elisa Baldin; Paolo Tinuper; Roberto Michelucci; Massimo Galeotti; Piero de Carolis; Roberto D'Alessandro
Journal:  J Neurol       Date:  2008-01-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.